GMP-Source® Gene Synthesis

GMP-Source® Gene Synthesis for Neoantigen Therapeutics Production

Designed to meet the needs of rapid gene synthesis for novel cancer treatments based on neoantigens, this service enables clients to have an end-to-end clinical manufacturing production process that meets their compliance and timeline requirements as well as protects their intellectual property. 

  • Rapid turnaround time
  • Segregated manufacturing environment
  • Raw material and process traceability 

We also offer standard research gene synthesis services for your plasmid production projects.  For more information please see our Full-Service Gene Synthesis page.

Request more information on GMP-Source® Gene Synthesis